...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.
【24h】

Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.

机译:通过连续的体内选择和转移特性研究建立具有多个转移潜能的逐步转移人肝癌细胞模型系统。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To establish a "stepwise metastatic human hepatocellular carcinoma (HCC) cell model system" for in-depth study of the underlying mechanisms of HCC metastasis. METHODS: Using MHCC97- a metastatic human hepatocellular carcinoma (HCC) cell line reported in 1999-as the parent cells, we subsequently established three cell lines (MHCC97-L, HMCC97-H, and HCCLM3) with increasing spontaneous metastatic potential. Now, the fourth cell line with unique multiple metastatic characteristics has been established by six rounds of in vivo selection. RESULTS: This cell line, designated as HCCLM6, is a polygonal epithelial cell with hypotriploid karyotype, the modal chromosomes are 55-58, and marker chromosomal abnormalities include i(1) (q10), i(8)(q10), der (4) t(4;8)(q31;q22), i(X)(q10). The cell population doubling time was 32 h. Fluorescent PCR showed HBV DNA integration in the cellular genome. Thirty-five days after HCCLM6 was injected subcutaneously into BALB/c nude mice, prominent lung metastases occurred in 100% of the recipient animals. When tumor tissue was orthotopically implanted into the liver of nude mouse, widespread loco-regional and pulmonary metastases occurred. Inoculation of this cell into the footpad of nude mice also produced 75% regional lymph node metastasis. Compared with MHCC97-L which was not metastastatic via subcutaneous or footpad inoculation and 40% metastatic via orthotopic inoculation, HCCLM6 had increased expression of matrix metalloproteinase (MMP-2 and MMP-9) and cytokeratin 19 (CK19), and decreased expression of Rb2/p130. The establishment of this new cell line has completed our stepwise metastatic HCC cell mode system, which was characterized by a similar genetic background but with significant differences in spontaneous metastasis behavior. CONCLUSIONS: The study supports the theory that cancer metastasis is a highly selective dynamic process and the cell model system could be a useful platform for the study of HCC metastasis.
机译:目的:建立“逐步转移性人类肝细胞癌(HCC)细胞模型系统”,以深入研究肝癌转移的潜在机制。方法:使用MHCC97-1999年报道的转移性人类肝细胞癌(HCC)细胞系作为亲代细胞,我们随后建立了三个具有自发转移潜力的细胞系(MHCC97-L,HMCC97-H和HCCLM3)。现在,通过六轮体内选择已经建立了具有独特的多种转移特性的第四种细胞系。结果:该细胞系命名为HCCLM6,是具有三倍体核型的多边形上皮细胞,模态染色体为55-58,标记染色体异常包括i(1)(q10),i(8)(q10),der( 4)t(4; 8)(q31; q22),i(X)(q10)。细胞群体倍增时间为32小时。荧光PCR显示HBV DNA整合在细胞基因组中。在将HCCLM6皮下注射到BALB / c裸鼠中后的第35天,在100%的受体动物中发生了明显的肺转移。当将肿瘤组织原位植入裸鼠的肝中时,发生了广泛的局部区域和肺转移。将该细胞接种到裸鼠的脚垫中也产生了75%的区域淋巴结转移。与通过皮下或足垫接种无转移且通过原位接种转移无转移的MHCC97-L相比,HCCLM6的基质金属蛋白酶(MMP-2和MMP-9)和细胞角蛋白19(CK19)的表达增加,而Rb2的表达减少/ p130。这种新细胞系的建立已完成了我们的逐步转移性HCC细胞模式系统,其特征是具有相似的遗传背景,但自发转移行为存在显着差异。结论:该研究支持以下理论:癌症转移是高度选择性的动态过程,细胞模型系统可能是研究肝癌转移的有用平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号